CARIS LIFE SCIENCES, INC. for CARIS LIFE SCIENCES, INC.
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 20, 2012 | $52,121 | Replaced |
| 2nd Quarter - Amendment | Jul 27, 2012 | $52,121 | Replaced |
| 2nd Quarter - Amendment | Jul 27, 2012 | $52,121 | Yes |
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY JENSEN CUNNIFFE | Asst. to the Speaker of the House for Policy |
Medicare/Medicaid MMM
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY JENSEN CUNNIFFE | Asst. to the Speaker of the House for Policy |
Insurance INS
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY JENSEN CUNNIFFE | Asst. to the Speaker of the House for Policy |
Medical/Disease Research/Clinical Labs MED
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY JENSEN CUNNIFFE | Asst. to Speaker of the House for Policy |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.